Mark C. Genovese
0000-0001-5294-4503
Publication & Citation Trends
Publications
429 total
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis PDF
Cited by 1,243
OpenAlex
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Cited by 1,007
OpenAlex
Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study
Cited by 856
OpenAlex
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks
Cited by 1,634
OpenAlex
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition PDF
Cited by 1,240
OpenAlex
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
Cited by 733
OpenAlex
Research Topics
Rheumatoid Arthritis Research and Therapies
(297)
Spondyloarthritis Studies and Treatments
(110)
Chronic Lymphocytic Leukemia Research
(96)
Autoimmune and Inflammatory Disorders Research
(91)
Systemic Lupus Erythematosus Research
(64)
Affiliations
Cedars-Sinai Medical Center
Brigham and Women's Hospital
American College of Rheumatology
Mount Sinai Hospital
Allegheny Health Network